High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles

Immunogenetics

Volumn 59, Issue 7, 2007, Pages 525-537

  Houtchens, Kathleen A ^a   Nichols, Robert J ^a   Ladner, Martha B ^a   Boal, Hannah E ^a   Sollars, Cristina ^a   Geraghty, Daniel E ^b   Davis, Lee M ^b   Parham, Peter ^c   Trachtenberg, Elizabeth A ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genotyping; HLA; KIR; MALDI TOF; SNP

Indexed keywords

GENOMIC DNA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; AMERICAN INDIAN; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; HISPANIC; HUMAN; HUMAN CELL; IMMUNOGENETICS; KIR2DL1 GENE; KIR2DL5 GENE; KIR2DS5 GENE; KIR3DL1 GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RECEPTOR GENE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CELL LINE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VARIATION (GENETICS);

EID: 34249821952     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-007-0222-x     Document Type: Article

References (35)

1. Bottino C, Castriconi R, Moretta L, Moretta A (2005) Cellular ligands of activating NK receptors. Trends Immunol 26:221-226
2. Carrington M, Norman PJ (2003) The KIR gene cluster. NCBI Bookshelf
3. Christiansen FT, Gaudieri S, De Santis D, Moore CB, Witt CS, James IR (2003) NK Receptor genes are predictors of HIV progression. Hum Immunol 64(Suppl 1):S12
4. Cook MA, Norman PJ, Curran MD, Maxwell LD, Briggs DC, Middleton D, Vaughan RW (2003) A multi-laboratory characterization of the KIR genotypes of 10th International Histocompatibility Workshop cell lines. Hum Immunol 64:567-571
5. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF, Moss PA, Briggs DC (2004) The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 103:1521-1526
6. Crum KA, Logue SE, Curran MD, Middleton D (2000) Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 56:313-326
7. Dupont B, Selvakumar A, Steffens U (1997) The killer cell inhibitory receptor genomic region on human chromosome 19q13.4. Tissue Antigens 49:557-563
8. Gagne K, Brizard G, Gueglio B, Milpied N, Herry P, Bonneville F, Cheneau ML, Schleinitz N, Cesbron A, Follea G, Harrousseau JL, Bignon JD (2002) Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 63:271-280
9. Garcia CA, Robinson J, Shilling HG, Guethlein LA, Parham P, Madrigal JA, Marsh SG (2004) KIR gene characterisation of HLA homozygous cell lines, HLA 2004. 13th IHWS NK/KIR Joint Report
10. Gomez-Lozano N, Vilches C (2002) Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 59:184-193
11. Gomez-Lazano N, Vilches C (2004) Erratum. Tissue Antigens 64:629
12. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C (2002) Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 54:314-319
13. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200:957-965
14. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305:872-874
15. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31:429-434
16. Mizuki M, Eklund A, Grunewald J (2000) Altered expression of natural killer cell inhibitory receptors (KIRs) on T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 17:54-59
17. Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, Witte T (2004) Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50:1561-1565
18. Moretta A (2002) Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2:957-964
19. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173:4273-4276
20. Parham P (2003) Killer Cell Immunoglobulin like receptors: diverse species specific components of innate immunity. Immunology Suppl 110:21
21. Parham P, McQueen KL (2003) Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nat Rev Immunol 3:108-122
22. Rajalingam R, Parham P, Abi-Rached L (2004) Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors. J Immunol 172:356-369
23. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-2100
24. Selvakumar A, Steffens U, Dupont B (1997a) Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev 155:183-196
25. Selvakumar A, Steffens U, Palanisamy N, Chaganti RS, Dupont B (1997b) Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. Tissue Antigens 49:564-573
26. Shilling HG, Lienert-Weidenbach K, Valiante NM, Uhrberg M, Parham P (1998) Evidence for recombination as a mechanism for KIR diversification. Immunogenetics 48:413-416
27. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P (2002) Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 168:2307-2315
28. Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P (2003) Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 101:3730-3740
29. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E, Funkhouser R, Fugate M, Theiler J, Hsu YS, Kunstman K, Wu S, Phair J, Erlich H, Wolinsky S (2003) Advantage of rare HLA supertype in HIV disease progression. Nat Med 9:928-935
30. Trachtenberg EA, Sollars C, Korber B, Erlich EH, Wolinsky S, Kepler T (2004) Natural killer cell immunogloblin-like receptors (KIR) are associated with protective effect in HIV-1 transmission and disease progression in the Chicago Multicenter AIDS Cohort Study (MACS). 8th Annual Meeting for the Society of Natural Immunity and the 20th International Natural Killer Cell Workshop, Noordwijkerhout, The Netherlands
31. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753-763
32. Valiante NM, Lienert K, Shilling HG, Smits BJ, Parham P (1997) Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev 155:155-164
33. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ (2003) KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52:2639-2642
34. Vilches C, Rajalingam R, Uhrberg M, Gardiner CM, Young NT, Parham P (2000) KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol 164:5797-5804
35. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT (1999) Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 68:1784-1789